000 | 01955 a2200625 4500 | ||
---|---|---|---|
005 | 20250515034345.0 | ||
264 | 0 | _c20060908 | |
008 | 200609s 0 0 eng d | ||
022 | _a0091-7451 | ||
024 | 7 |
_a10.1101/sqb.2005.70.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAdams, J M | |
245 | 0 | 0 |
_aSubversion of the Bcl-2 life/death switch in cancer development and therapy. _h[electronic resource] |
260 |
_bCold Spring Harbor symposia on quantitative biology _c2005 |
||
300 |
_a469-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aGenes, bcl-2 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aMolecular Mimicry |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aNitrophenols |
650 | 0 | 4 | _aPiperazines |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSulfonamides |
700 | 1 | _aHuang, D C S | |
700 | 1 | _aStrasser, A | |
700 | 1 | _aWillis, S | |
700 | 1 | _aChen, L | |
700 | 1 | _aWei, A | |
700 | 1 | _avan Delft, M | |
700 | 1 | _aFletcher, J I | |
700 | 1 | _aPuthalakath, H | |
700 | 1 | _aKuroda, J | |
700 | 1 | _aMichalak, E M | |
700 | 1 | _aKelly, P N | |
700 | 1 | _aBouillet, P | |
700 | 1 | _aVillunger, A | |
700 | 1 | _aO'Reilly, L | |
700 | 1 | _aBath, M L | |
700 | 1 | _aSmith, D P | |
700 | 1 | _aEgle, A | |
700 | 1 | _aHarris, A W | |
700 | 1 | _aHinds, M | |
700 | 1 | _aColman, P | |
700 | 1 | _aCory, S | |
773 | 0 |
_tCold Spring Harbor symposia on quantitative biology _gvol. 70 _gp. 469-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1101/sqb.2005.70.009 _zAvailable from publisher's website |
999 |
_c16459064 _d16459064 |